Point72 Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Buy
2,900
+1,300
+81% +$459K ﹤0.01% 2753
2026
Q2
$574K Sell
1,600
-385,500
-100% -$118M ﹤0.01% 3117
2026
Q1
$97M Buy
387,100
+385,500
+24,094% +$95.9M 0.12% 177
2025
Q4
$440K Buy
+1,600
New +$438K ﹤0.01% 3297

Other funds holding WST

Point72 Asset Management's WST Position: Q3 2026 in Review

Point72 Asset Management increased its West Pharmaceutical (WST) stake by 13% in Q3 2026, buying an estimated $13.2M and bringing the position to 320,705 shares worth $119M. The position accounts for 0.13% of the portfolio, ranked #172.

Point72 Asset Management first reported a position in WST in Q2 2019 and has held it in 23 quarters since. The position peaked at $173M in Q3 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Point72 Asset Management held 320,705 shares of West Pharmaceutical worth $119M as of Q3 2026.
  • Point72 Asset Management bought 37,309 West Pharmaceutical shares in Q3 2026, an estimated $13.2M.
  • West Pharmaceutical made up 0.13% of Point72 Asset Management's portfolio in Q3 2026, its #172 holding.
  • Point72 Asset Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 23 quarters since.
  • Point72 Asset Management's West Pharmaceutical position peaked at $173M in Q3 2025.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.